The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
Official Title: A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
Study ID: NCT01331421
Brief Summary: The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
BioKinetic Clinical Applications, Inc., Springfield, Missouri, United States
Name: Dennis N Morrison, D.O.
Affiliation: Bio-Kinetic Clinical Applications, Inc.
Role: PRINCIPAL_INVESTIGATOR